Dear Melanoma Patients, Advocates, Carers,
I am a stage IV melanoma patient residing in Belgium. I am the president and founder of the melanoma independent community advisory board (M-ICAB). Our purpose is to develop innovative approaches and solutions for melanoma patients that would not be achievable by single actors alone, based on a true and meaningful partnership with researchers/clinicians, the pharmaceutical/diagnostic companies, the EU and regulatory bodies.
Dear Melanoma Patients, Advocates, Carers,
I am a stage IV melanoma patient residing in Belgium. I am the president and founder of the melanoma independent community advisory board (M-ICAB). Our purpose is to develop innovative approaches and solutions for melanoma patients that would not be achievable by single actors alone, based on a true and meaningful partnership with researchers/clinicians, the pharmaceutical/diagnostic companies, the EU and regulatory bodies.
Given the recent approval by FDA and EMA of innovative therapies for advanced melanoma we are conducting a short survey (6 question maximum 7 minutes) to get a better understanding of the condition of access to these new treatments across Europe. This information is essential for EU melanoma patient advocates whom are fighting for their right to a better quality of life. To facilitate the completion of the survey you can go to the following link:https://www.surveymonkey.com/s/Z7J22F7
We would greatly appreciate your time and partnership if you have EU patients accessing your boards,
Best
Patricia Garcia-Prieto
President and founder
Melanoma Independent Community Advisory Board
http://www.m-icab.org
Volunteer Patient Advocate
European Cancer Patient Coalition
contact: patricia.garcia@ecpc-online.org
.
.
